| Mar 2, 2026 |
Mar 3, 2026 |
SATO VICKI L
|
Director |
Sell |
46.3
|
-22,000
|
-1.92%
|
✓
|
$209.2K |
| Feb 24, 2026 |
Feb 26, 2026 |
SATO VICKI L
|
Director |
Sell |
37.5
|
-42,377
|
-3.57%
|
✓
|
$413.4K |
| Feb 24, 2026 |
Feb 26, 2026 |
Sabatini Brent
|
SVP, Chief Accounting Officer |
Sell |
44.4
|
-1,430
|
-2.01%
|
✓
|
$13.6K |
| Feb 24, 2026 |
Feb 26, 2026 |
O'Byrne Jason
|
CFO |
Sell |
50.6
|
-1,634
|
-0.99%
|
✓
|
$15.6K |
| Feb 24, 2026 |
Feb 26, 2026 |
Eisner Mark
|
EVP and Chief Medical Officer |
Sell |
44.4
|
-3,505
|
-2.22%
|
✓
|
$34K |
| Feb 24, 2026 |
Feb 26, 2026 |
de Verneuil Vanina
|
EVP, General Counsel, Corp Sec |
Sell |
26.3
|
-16,817
|
-12.96%
|
✓
|
$164.2K |
| Feb 24, 2026 |
Feb 26, 2026 |
De Backer Marianne
|
CEO |
Sell |
46.3
|
-14,762
|
-1.36%
|
✓
|
$140.7K |
| Feb 22, 2026 |
Feb 24, 2026 |
Sabatini Brent
|
SVP, Chief Accounting Officer |
Sell |
91.3
|
+23,171
|
48.40%
|
✓
|
$13.6K |
| Feb 22, 2026 |
Feb 24, 2026 |
O'Byrne Jason
|
CFO |
Sell |
91.3
|
+52,911
|
47.52%
|
✓
|
$15.6K |
| Feb 22, 2026 |
Feb 24, 2026 |
Eisner Mark
|
EVP and Chief Medical Officer |
Sell |
91.3
|
+52,911
|
50.58%
|
✓
|
$15.6K |
| Feb 22, 2026 |
Feb 24, 2026 |
de Verneuil Vanina
|
EVP, General Counsel, Corp Sec |
Sell |
91.3
|
+50,555
|
63.80%
|
✓
|
$33.1K |
| Feb 22, 2026 |
Feb 24, 2026 |
De Backer Marianne
|
CEO |
Sell |
95.0
|
+265,961
|
32.33%
|
✓
|
$141.9K |
| Feb 13, 2026 |
Feb 18, 2026 |
Sabatini Brent
|
SVP, Chief Accounting Officer |
Sell |
40.6
|
-1,530
|
-3.10%
|
✓
|
$11.9K |
| Feb 2, 2026 |
Feb 3, 2026 |
SATO VICKI L
|
Director |
Sell |
46.3
|
-22,000
|
-1.89%
|
✓
|
$169.7K |
| Jan 2, 2026 |
Jan 5, 2026 |
SATO VICKI L
|
Director |
Sell |
46.3
|
-22,000
|
-1.85%
|
✓
|
$130.4K |
| Dec 1, 2025 |
Dec 3, 2025 |
SVF Endurance (Cayman) Ltd
|
10% Owner |
Sell |
40.0
|
-191,854
|
-1.38%
|
✓
|
$1.1M |
| Dec 1, 2025 |
Dec 2, 2025 |
SATO VICKI L
|
Director |
Sell |
45.0
|
-22,000
|
-1.82%
|
✓
|
$132.1K |
| Nov 26, 2025 |
Dec 1, 2025 |
SVF Endurance (Cayman) Ltd
|
10% Owner |
Sell |
40.0
|
-189,431
|
-1.34%
|
✓
|
$1.2M |
| Nov 24, 2025 |
Nov 26, 2025 |
SVF Endurance (Cayman) Ltd
|
10% Owner |
Sell |
32.5
|
-463,774
|
-3.18%
|
✓
|
$2.9M |
| Nov 17, 2025 |
Nov 18, 2025 |
O'Byrne Jason
|
CFO |
Sell |
46.3
|
-6,799
|
-5.79%
|
✗
|
$37.8K |
| Nov 5, 2025 |
Nov 7, 2025 |
de Verneuil Vanina
|
EVP, General Counsel, Corp Sec |
Sell |
45.0
|
-2,385
|
-2.96%
|
✓
|
$12.3K |
| Nov 3, 2025 |
Nov 4, 2025 |
de Verneuil Vanina
|
EVP and General Counsel |
Sell |
47.5
|
-1,365
|
-1.67%
|
✗
|
$8K |
| Nov 3, 2025 |
Nov 4, 2025 |
SATO VICKI L
|
Director |
Sell |
45.0
|
-22,000
|
-1.79%
|
✓
|
$124K |
| Oct 28, 2025 |
Oct 30, 2025 |
SVF Endurance (Cayman) Ltd
|
10% Owner |
Sell |
50.0
|
-24,553
|
-0.17%
|
✓
|
$159.7K |
| Oct 24, 2025 |
Oct 28, 2025 |
SVF Endurance (Cayman) Ltd
|
10% Owner |
Sell |
45.0
|
-113,099
|
-0.77%
|
✓
|
$679.9K |
| Oct 22, 2025 |
Oct 24, 2025 |
SVF Endurance (Cayman) Ltd
|
10% Owner |
Sell |
40.0
|
-298,649
|
-1.99%
|
✓
|
$1.8M |
| Oct 20, 2025 |
Oct 22, 2025 |
SVF Endurance (Cayman) Ltd
|
10% Owner |
Sell |
36.3
|
-330,210
|
-2.15%
|
✓
|
$2.1M |
| Oct 15, 2025 |
Oct 17, 2025 |
SVF Endurance (Cayman) Ltd
|
10% Owner |
Sell |
50.0
|
-29,515
|
-0.19%
|
✓
|
$179.6K |
| Oct 9, 2025 |
Oct 14, 2025 |
SVF Endurance (Cayman) Ltd
|
10% Owner |
Sell |
40.0
|
-251,360
|
-1.61%
|
✓
|
$1.5M |
| Oct 7, 2025 |
Oct 9, 2025 |
SVF Endurance (Cayman) Ltd
|
10% Owner |
Sell |
32.5
|
-538,375
|
-3.33%
|
✓
|
$3.2M |
| Oct 3, 2025 |
Oct 7, 2025 |
SVF Endurance (Cayman) Ltd
|
10% Owner |
Sell |
32.5
|
-524,297
|
-3.14%
|
✓
|
$2.9M |
| Oct 1, 2025 |
Oct 2, 2025 |
SATO VICKI L
|
Director |
Sell |
45.0
|
-22,000
|
-1.75%
|
✓
|
$128.4K |
| Sep 2, 2025 |
Sep 3, 2025 |
SATO VICKI L
|
Director |
Sell |
45.0
|
-22,000
|
-1.72%
|
✓
|
$109.8K |
| Aug 1, 2025 |
Aug 4, 2025 |
SATO VICKI L
|
Director |
Sell |
45.0
|
-22,000
|
-1.69%
|
✓
|
$109.7K |
| Jul 15, 2025 |
Jul 17, 2025 |
Eisner Mark
|
EVP and Chief Medical Officer |
Sell |
28.8
|
-10,382
|
-9.03%
|
✓
|
$56.8K |
| Jul 1, 2025 |
Jul 2, 2025 |
SATO VICKI L
|
Director |
Sell |
45.0
|
-22,000
|
-1.67%
|
✓
|
$112.2K |
| Jun 9, 2025 |
Jun 9, 2025 |
MORE ROBERT J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2025 |
Jun 6, 2025 |
BISCHOFBERGER NORBERT W
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 30, 2025 |
Jun 2, 2025 |
Sigal Charles Elliott
|
Director |
Neutral |
90.0
|
+8,000
|
23.66%
|
✗
|
- |
| May 30, 2025 |
Jun 2, 2025 |
SATO VICKI L
|
Director |
Neutral |
67.5
|
+8,000
|
0.61%
|
✗
|
- |
| May 30, 2025 |
Jun 2, 2025 |
Ramasastry Saira
|
Director |
Neutral |
90.0
|
+8,000
|
54.72%
|
✗
|
- |
| May 30, 2025 |
Jun 2, 2025 |
Napolitano Janet
|
Director |
Sell |
91.3
|
+4,800
|
41.32%
|
✓
|
$16.1K |
| May 30, 2025 |
Jun 2, 2025 |
MORE ROBERT J
|
Director |
Neutral |
77.5
|
+8,000
|
1.47%
|
✗
|
- |
| May 30, 2025 |
Jun 2, 2025 |
Hatfield Jeffrey S.
|
Director |
Neutral |
90.0
|
+8,000
|
33.60%
|
✗
|
- |
| May 30, 2025 |
Jun 2, 2025 |
Farid Ramy
|
Director |
Neutral |
90.0
|
+8,000
|
50.00%
|
✗
|
- |
| May 30, 2025 |
Jun 2, 2025 |
BISCHOFBERGER NORBERT W
|
Director |
Neutral |
90.0
|
+8,000
|
50.00%
|
✗
|
- |
| Apr 3, 2025 |
Apr 4, 2025 |
De Backer Marianne
|
CEO |
Sell |
40.0
|
-79,712
|
-8.83%
|
✗
|
$474.2K |
| Feb 26, 2025 |
Feb 27, 2025 |
de Verneuil Vanina
|
EVP and General Counsel |
Sell |
28.8
|
-7,373
|
-8.49%
|
✓
|
$67.4K |
| Feb 24, 2025 |
Feb 25, 2025 |
SCANGOS GEORGE A
|
Director |
Sell |
47.5
|
-10,056
|
-0.26%
|
✗
|
$95.1K |
| Feb 24, 2025 |
Feb 25, 2025 |
HANLY ANN M.
|
EVP & Chief Technology Officer |
Sell |
42.5
|
-14,168
|
-10.73%
|
✗
|
$133.9K |
| Feb 22, 2025 |
Feb 25, 2025 |
O'Byrne Jason
|
CFO |
Neutral |
90.0
|
+40,000
|
53.33%
|
✗
|
- |
| Feb 22, 2025 |
Feb 25, 2025 |
Eisner Mark
|
EVP and Chief Medical Officer |
Neutral |
90.0
|
+40,000
|
53.33%
|
✗
|
- |
| Feb 22, 2025 |
Feb 25, 2025 |
Sabatini Brent
|
SVP, Chief Accounting Officer |
Sell |
91.3
|
+18,438
|
65.41%
|
✗
|
$14.8K |
| Feb 22, 2025 |
Feb 25, 2025 |
De Backer Marianne
|
CEO |
Sell |
95.0
|
+223,878
|
33.00%
|
✗
|
$152.4K |
| Feb 22, 2025 |
Feb 25, 2025 |
de Verneuil Vanina
|
EVP and General Counsel |
Sell |
91.3
|
+29,860
|
52.41%
|
✗
|
$48.6K |
| Feb 18, 2025 |
Feb 19, 2025 |
SCANGOS GEORGE A
|
Director |
Sell |
47.5
|
-10,964
|
-0.29%
|
✗
|
$107.6K |
| Feb 13, 2025 |
Feb 14, 2025 |
Sabatini Brent
|
SVP, Chief Accounting Officer |
Sell |
46.3
|
-1,562
|
-5.25%
|
✗
|
$14.3K |
| Jan 8, 2025 |
Jan 8, 2025 |
SATO VICKI L
|
Director |
Sell |
47.5
|
-10,960
|
-0.83%
|
✓
|
$137.2K |
| Dec 2, 2024 |
Dec 4, 2024 |
de Verneuil Vanina
|
EVP and General Counsel |
Sell |
52.5
|
-76
|
-0.13%
|
✗
|
$624.7 |
| Nov 15, 2024 |
Nov 18, 2024 |
O'Byrne Jason
|
CFO |
Neutral |
90.0
|
+75,000
|
100.00%
|
✗
|
- |
| Nov 6, 2024 |
Nov 7, 2024 |
de Verneuil Vanina
|
EVP and General Counsel |
Sell |
36.3
|
-4,397
|
-7.16%
|
✓
|
$44.5K |
| Nov 1, 2024 |
Nov 5, 2024 |
de Verneuil Vanina
|
EVP and General Counsel |
Sell |
36.3
|
-3,750
|
-5.76%
|
✓
|
$32.3K |
| Oct 23, 2024 |
Oct 24, 2024 |
SCANGOS GEORGE A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 3, 2024 |
O'Byrne Jason
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 2, 2024 |
Sabatini Brent
|
SVP, Chief Accounting Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 2, 2024 |
de Verneuil Vanina
|
EVP and General Counsel |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 9, 2024 |
Sep 10, 2024 |
Napolitano Janet
|
Director |
Sell |
10.0
|
-12,190
|
-51.21%
|
✓
|
$95K |
| Jul 15, 2024 |
Jul 16, 2024 |
Eisner Mark
|
EVP and Chief Medical Officer |
Neutral |
90.0
|
+75,000
|
100.00%
|
✗
|
- |
| Jun 12, 2024 |
Jun 12, 2024 |
De Backer Marianne
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 11, 2024 |
Jun 12, 2024 |
Ramasastry Saira
|
Director |
Sell |
26.3
|
-4,000
|
-21.48%
|
✗
|
$43.8K |
| May 30, 2024 |
Jun 3, 2024 |
Sigal Charles Elliott
|
Director |
Neutral |
90.0
|
+8,000
|
31.00%
|
✗
|
- |
| May 30, 2024 |
Jun 3, 2024 |
SCANGOS GEORGE A
|
Director |
Neutral |
60.0
|
+8,000
|
0.21%
|
✗
|
- |
| May 30, 2024 |
Jun 3, 2024 |
SATO VICKI L
|
Director |
Neutral |
67.5
|
+8,000
|
0.61%
|
✗
|
- |
| May 30, 2024 |
Jun 3, 2024 |
Ramasastry Saira
|
Director |
Neutral |
90.0
|
+8,000
|
75.34%
|
✗
|
- |
| May 30, 2024 |
Jun 3, 2024 |
NELSEN ROBERT
|
Director |
Neutral |
55.0
|
+8,000
|
0.06%
|
✗
|
- |
| May 30, 2024 |
Jun 3, 2024 |
Napolitano Janet
|
Director |
Neutral |
90.0
|
+8,000
|
50.61%
|
✗
|
- |
| May 30, 2024 |
Jun 3, 2024 |
MORE ROBERT J
|
Director |
Neutral |
77.5
|
+8,000
|
1.50%
|
✗
|
- |
| May 30, 2024 |
Jun 3, 2024 |
Hatfield Jeffrey S.
|
Director |
Neutral |
90.0
|
+8,000
|
50.61%
|
✗
|
- |
|
Jun 3, 2024 |
Eisner Mark
|
EVP and Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 29, 2024 |
May 31, 2024 |
Farid Ramy
|
Director |
Neutral |
90.0
|
+16,000
|
100.00%
|
✗
|
- |
|
May 31, 2024 |
Farid Ramy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 29, 2024 |
May 31, 2024 |
BISCHOFBERGER NORBERT W
|
Director |
Neutral |
90.0
|
+16,000
|
100.00%
|
✗
|
- |
|
May 31, 2024 |
BISCHOFBERGER NORBERT W
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 3, 2024 |
Apr 4, 2024 |
De Backer Marianne
|
CEO |
Sell |
40.0
|
-72,995
|
-9.71%
|
✗
|
$690.4K |
| Apr 1, 2024 |
Apr 2, 2024 |
HANLY ANN M.
|
EVP & Chief Technology Officer |
Sell |
46.3
|
-2,711
|
-2.01%
|
✗
|
$27.3K |
| Mar 27, 2024 |
Mar 28, 2024 |
Lee Sung
|
CFO |
Sell |
42.5
|
-6,008
|
-5.64%
|
✗
|
$59.4K |
| Feb 22, 2024 |
Feb 26, 2024 |
HANLY ANN M.
|
EVP & Chief Technology Officer |
Sell |
95.0
|
+20,204
|
17.63%
|
✗
|
$123.5K |
| Feb 22, 2024 |
Feb 26, 2024 |
De Backer Marianne
|
CEO |
Neutral |
90.0
|
+175,000
|
30.36%
|
✗
|
- |
| Feb 22, 2024 |
Feb 26, 2024 |
Lee Sung
|
CFO |
Neutral |
90.0
|
+40,000
|
60.15%
|
✗
|
- |
| Feb 22, 2024 |
Feb 26, 2024 |
Pang Phillip
|
EVP & Chief Medical Officer |
Sell |
42.5
|
-14,568
|
-5.50%
|
✗
|
$146.3K |
| Feb 22, 2024 |
Feb 26, 2024 |
SCANGOS GEORGE A
|
Director |
Sell |
45.0
|
-27,750
|
-0.72%
|
✓
|
$307.3K |
| Feb 16, 2024 |
Feb 20, 2024 |
SCANGOS GEORGE A
|
Director |
Sell |
45.0
|
-27,750
|
-0.71%
|
✓
|
$283.8K |
| Feb 16, 2024 |
Feb 16, 2024 |
Pang Phillip
|
EVP & Chief Medical Officer |
Sell |
46.3
|
-3,321
|
-1.24%
|
✗
|
$34K |
| Jan 2, 2024 |
Jan 3, 2024 |
Pang Phillip
|
EVP & Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 19, 2023 |
Oct 20, 2023 |
MORE ROBERT J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 17, 2023 |
Oct 18, 2023 |
SCANGOS GEORGE A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 15, 2023 |
Sep 18, 2023 |
SCANGOS GEORGE A
|
Director |
Neutral |
27.5
|
-1,877,590
|
-33.65%
|
✗
|
- |
| Jun 30, 2023 |
Jul 5, 2023 |
SVF Endurance (Cayman) Ltd
|
10% Owner |
Sell |
57.5
|
-700
|
0.00%
|
✓
|
$17.6K |
| Jun 30, 2023 |
Jul 3, 2023 |
SATO VICKI L
|
Director |
Sell |
42.5
|
-18,000
|
-1.35%
|
✓
|
$443.9K |
| Jun 28, 2023 |
Jun 30, 2023 |
SVF Endurance (Cayman) Ltd
|
10% Owner |
Sell |
42.5
|
-96,952
|
-0.58%
|
✓
|
$2.4M |